Respiratory tract infections and tuberculosis are among the leading reasons for seeking medical care. In this report the most recent advances in the field of clinical research and basic sciences of respiratory infections and tuberculosis are presented through the analysis of some of the best abstracts presented at the 20(th) ERS Congress in Barcelona and their subsequent publications in major journals.
The role of viruses in COPD exacerbations, the importance of new biomarkers in the management and risk assessment of LRTIs, new modalities of treatment of respiratory infections as well as new tools for the diagnosis of latent and active tuberculosis in special subgroups of patients (children, immunocompromised individuals), and the new epidemiological threat of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis cases are discussed.
Authors: Miravitlles M, Sotgiu G, Dimopoulos G, Rohde G, Centis R, Ferrara G, Ewig S, Blasi F, Migliori GB
Read Full Article
